RAS mutation identifies a poor prognostic molecular subtype of therapy-related myeloid neoplasm

Chung Hoow Kok, Aref Al-Kali, Daniel Thomas, Rong He, Monika M. Kutyna, Hassan Alkhateeb, Kelly Lim, Antoine N. Saliba, Carla Toop, Aasiya Matin, Hamish Scott, Naseema Gangat, Anna Brown, Abhishek Mangaonkar, Christopher N. Hahn, Kebede Begna, Kevin Hung, Patricia Greipp, William J. Hogan, Mrinal PatnaikMithun Shah, Devendra K. Hiwase

Research output: Contribution to journalLetterpeer-review

Original languageEnglish
Pages (from-to)3814-3818
Number of pages5
JournalBlood Advances
Volume9
Issue number15
DOIs
Publication statusPublished or Issued - 12 Aug 2025

Keywords

  • RAS mutation
  • Myeloid neoplasm
  • t-MN
  • NRAS
  • KRAS
  • AML
  • myelodysplastic syndromes

ASJC Scopus subject areas

  • Hematology

Cite this